Joan Miller

Chief and Chair of the Department of Ophthalmology, Massachusetts Eye and Ear, Mass General Hospital and Harvard Medical School, Boston

Not only a pioneer of photodynamic therapy using verteporfin, Joan Miller also helped to define the role of VEGF in retinal vascular disease, helping to form the scientific basis of angiogenesis inhibitor drug use in the eye – something that she and six of her Harvard Medical School colleagues received the 2014 António Champalimaud Vision Award for. Today she continues to investigate the molecular pathophysiology of vision loss and to develop improved therapies for retinal disease.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016